Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(3 sites)

Thailand

Siriraj Hospital, Bangkok, Bangkoknoi

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Mueang Chiang Mai District

King Chulalongkorn Memorial Hospital, Bangkok, Pathumwan